Bristol Myers Squibb Co. Stock Sheds 3.8%, Underperforms Peers

Dow Jones2026/10/05 20:35

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Bristol Myers Squibb Co. shed 3.8% to $58.81 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. This was the stock's fifth consecutive day of losses. Bristol Myers Squibb Co. closed 14.3% short of its 52-week high of $68.64, which the company achieved on August 19th. The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Abbott Laboratories rose 2.67% to $100.10. Trading volume totaled 19.1 million, compared to the 50-day average of 11.3 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:35 ET (20:35 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The value of cryptocurrency assets held by the U.S. government has shrunk by $16 billion from last year’s peak.

AiCoin•2026/10/11 03:23

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35